New Alzheimer Disease Data Have Been Reported by Investigators at University of Pittsburgh (Insights Into the Use of Biomarkers In Clinical Trials In Alzheimer's ' S Disease).

A recent report from the University of Pittsburgh discusses the importance of biomarkers in clinical trials for Alzheimer's disease. The research highlights the role of biomarkers in population selection and disease monitoring, particularly in trials for drugs targeting amyloid-(3. The study emphasizes the growing significance of biomarkers in drug development and explores various applications of biomarkers in Alzheimer's disease research. For more information, the full report can be found in EBioMedicine, with contact information available for the researchers involved. [Extracted from the article]